Integrated study on anti-inflammatory and anti-atopic dermatitis efficacy of Saposhnikoviae Radix: UPLC-MS/GC-MS metabolomics and in vitro/in vivo experimental models | Synapse
March 3, 2026
Integrated study on anti-inflammatory and anti-atopic dermatitis efficacy of Saposhnikoviae Radix: UPLC-MS/GC-MS metabolomics and in vitro/in vivo experimental models
Key Points
Saposhnikoviae radix shows significant anti-inflammatory activity in atopic dermatitis models, indicating its therapeutic potential.
Key evidence reveals multiple beneficial compounds identified through UPLC-MS and GC-MS, enhancing the understanding of its effects.
The study employs both in vitro and in vivo experimental models to validate the efficacy of the intervention in various settings.
These findings highlight the potential for new treatments targeting inflammation, though further validation in clinical settings is necessary.